Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.61 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834234 | 0.98 | DNM1 (0.59) | DNM1HTTSMN1; SMN2KMT2ALMNA | |
| Iodide SCHEMBL8912913 | 0.93 | DNM1 (0.58) | DNM1HTTKMT2ALMNAMEN1 | |
| SCHEMBL4808190 | 0.90 | DNM1 (0.64) | DNM1HTTSMN1; SMN2KMT2ALMNA | |
| SCHEMBL7091336 | 0.90 | DNM1 (0.64) | DNM1HTTSMN1; SMN2KMT2ALMNA | |
| SCHEMBL7089797 | 0.90 | DNM1 (0.64) | DNM1HTTSMN1; SMN2KMT2ALMNA | |
| SCHEMBL25834237 | 0.90 | DNM1 (0.52) | DNM1HTTSMN1; SMN2KMT2AMEN1 | |
| Hydrochloric Acid SCHEMBL1683335 | 0.89 | DNM1 (0.62) | DNM1HTTKMT2AMEN1TSHR | |
| Hydrochloric Acid SCHEMBL1683346 | 0.89 | DNM1 (0.62) | DNM1HTTKMT2AMEN1TSHR | |
| Hydrochloric Acid SCHEMBL5552101 | 0.89 | DNM1 (0.62) | DNM1HTTKMT2AMEN1TSHR | |
| Hydrochloric Acid SCHEMBL4805429 | 0.89 | DNM1 (0.62) | DNM1HTTKMT2AMEN1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218523-A1 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218523-A1 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | HACD3, C9, HACD2 | DNM1 1502/4885HTT 657/4885SMN1; SMN2 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.